Manuel Díaz Rubio García-rekin lankidetzan egindako argitalpenak (9)

2010

  1. STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility

    Genes and Immunity, Vol. 11, Núm. 3, pp. 264-268

2009

  1. Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility

    Genes and Immunity, Vol. 10, Núm. 7, pp. 631-635

  2. Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease

    American Journal of Gastroenterology, Vol. 104, Núm. 8, pp. 1968-1975

  3. Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: A study in the spanish population and a meta-analysis

    Inflammatory Bowel Diseases, Vol. 15, Núm. 11, pp. 1697-1704

  4. Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15- Crohn's disease patients

    European Journal of Human Genetics, Vol. 17, Núm. 10, pp. 1304-1308

2008

  1. IL23R and IL12B polymorphisms in Spanish IBD patients: No evidence of interaction

    Inflammatory Bowel Diseases, Vol. 14, Núm. 9, pp. 1192-1196

  2. Polymorphisms in the selenoprotein S gene: Lack of association with autoimmune inflammatory diseases

    BMC Genomics, Vol. 9

2007

  1. Role of the PXR gene locus in inflammatory bowel diseases

    Inflammatory Bowel Diseases, Vol. 13, Núm. 12, pp. 1484-1487

  2. Strong protective effect of DR3 against ulcerative colitis in the Spanish population

    American Journal of Gastroenterology, Vol. 102, Núm. 12, pp. 2762-2766